Issue link: https://www.e-digitaleditions.com/i/626800
6 January 2016 Tablets & Capsules SANITARY/USDA-ACCEPTED • PNEUMATIC CONVEYING COMPONENTS & SYSTEMS • BATCH & CONTINUOUS OPERATION MULTI-INGREDIENT HANDLING SYSTEMS • BATCH WEIGHING & SCALING SYSTEMS • UL-CONTROLS & CONTROL PACKAGES FDA-APPROVED/CERTIFIED MATERIALS OF CONSTRUCTION • 21 CFR PART 11 COMPLIANCE MOBILE VACUUM CONVEYING SYSTEMS • CIP DESIGNS Let us solve your pneumatic conveying challenges. Visit vac-u-max.com/pneumatic or call 800-VAC-U-MAX. More than 60 years of custom application experience in the pharmaceutical industry. Over 10,000 different powder and bulk materials handled—including Free-Flowing and Non-Free Flowing Powders. Technical expertise including FAT and SAT validation. And an airtight perfor- mance guarantee. It's what makes VAC-U-MAX as unique and trusted as the pharmaceutical process automation solutions we design. From sanitary components to fully automated batch or continuous systems, we create pharmaceutical processing solutions entirely around your needs and goals. VAC-U-MAX Gel Cap, Capsule, and Coated Tablet Conveyor for Gentle Delivery of Product to Capsule Filling or Packaging Machines $1.2 billion by 2020, which would equal a compound annual growth rate of 7.1 percent. The forecast comes from an October 2015 report issued by MarketsandMarkets, Pune, India. Among the factors driving the pro- jected growth is more use of logistics and distribution services. The report, which segments the market by prod- ucts and services, phases, therapeutic areas, and regions, predicts that the oncology will account for the largest share of the global clinical trial sup- plies market in 2015. Polymer excipients market for OSDFs to grow by 16.8 percent ELMHURST, IL—The global mar- ket for polymer-based excipients used in oral solid dosage forms (OSDFs) to enhance solubility will see a 16.8 per- cent compound annual growth rate between 2014 and 2019, according to a report from Technavio. The increase in poorly water-soluble new chemical entities is driving growth. The report, "Global Polymer-based Solubility Enhancement Excipients Market for OSDF 2015-2019," cites several sup- pliers, including Ashland, BASF, Dow, Evonik, and Shin-Etsu. industry news FDA elevates dietary supplement program WASHINGTON, DC—The FDA created the Office of Dietary Supplement Programs, elevating it from division status under the Office of Nutrition Labeling and Dietary Supplements. The change will raise the profile of dietary supplements within the FDA and allow it to com- pete better for government resources, the Agency said. Dow, DuPont to merge MIDLAND, MI— Dow Chemical and DuPont, the nation's two largest chemical companies, agreed to merge. The companies will then divide into three separate entities. Both compa- nies supply pharmaceutical excipients, but it's not known which businesses will be sold, spun off, or otherwise affected by the merger. predicts excipient consumption in the region will increase at a compound annual growth rate (CAGR) of 13.4 percent through 2020. The report forecasts that excipient markets in the Middle East and Africa will grow at a CAGR of 8 percent through 2020. Clinical trial supplies market projected to exceed $1.2 billion by 2020 PUNE, INDIA—The global mar- ket for clinical trial supplies will reach $904.3 million in 2015 and exceed markets Southeast Asia to continue as top excipient market, report says PARSIPPANY, NJ—Southeast Asia is the fastest growing pharmaceutical market in the world, according to "Specialty Excipients for Oral Solid- Dosage-Form Pharmaceuticals: Emerging Markets Analysis and Opportunities." The report, issued by Kline Group, a consulting firm, also